Evidence map›Paper›PMID 37710296›Full record

ReviewOrphanet journal of rare diseases2023

Imerslund-Gräsbeck syndrome: a comprehensive review of reported cases.

Sandra D K Kingma, Julie Neven, An Bael, Marije E C Meuwissen, Machiel van den Akker

Open access · goldAbstract readReview
In one paragraph

Review in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Developmental regulation of intestinalbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Imerslund Grasbeck Syndrome: A Propos of Two Cases.Indian journal of pediatrics · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vitamin BInternational journal of molecular sciences · 2024
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sandra D K KingmaCentre for Metabolic Diseases, University Hospital Antwerp, University of Antwerp, Drie Eikenstraat 655, Edegem, Antwerp, 2650, Belgium.
Julie NevenDepartment of Pediatrics, University Hospital Antwerp, University of Antwerp, Drie Eikenstraat 655, Edegem, 2650, Belgium.
An BaelFaculty of medicine and health sciences, University of Antwerp, Antwerp, Belgium.
Marije E C MeuwissenCenter of Medical Genetics, University Hospital Antwerp, Drie Eikenstraat 655, Edegem, 2650, Belgium.
Machiel van den AkkerDepartment of Pediatrics, University Hospital Antwerp, University of Antwerp, Drie Eikenstraat 655, Edegem, 2650, Belgium. machiel.vandenakker@uza.be.
University of Antwerp · BEAntwerp University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imerslund-Gräsbeck syndrome (IGS) is a rare autosomal recessive disorder characterized by vitamin B12 malabsorption. Most patients present with non-specific symptoms attributed to vitamin B12 deficiency, and proteinuria. Patients may if untreated, develop severe neurocognitive manifestations. If recognized and treated with sufficient doses of vitamin B12, patients recover completely. We provide, for the first time, an overview of all previously reported cases of IGS. In addition, we provide a complete review of IGS and describe two new patients.

Indexed as

Anemia, MegaloblasticVitamin B 12 DeficiencyHumansMalabsorption SyndromesProteinuriaVitamin B 12Vitamin B 12Cobalamin deficiencyImerslund-Gräsbeck syndromeVitamin B12 deficiencyVitamin B12 malabsorption

Identifiers

PMID37710296
PMCPMC10500774
OpenAlexW4386744279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.